title: Considerations for developing an antiarrhythmic agent: a perspective from the pharmaceutical industry.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
authors.forename: M J
authors.initials: MJ
authors.lastname: Antonaccio
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000138:chemical synthesis; D002170:Canada; D004345:Drug Industry; D006801:Humans; D007885:Legislation, Pharmacy
chemical_list: D000889:Anti-Arrhythmia Agents